TrialsgrambetaRCTs are beautiful

PROVE-IT

2004

Pravastatin or Atorvastatin Evaluation and Infection Therapy — Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22)

In 4,162 patients after acute coronary syndrome, intensive atorvastatin 80 mg reduced death or major cardiovascular events compared with moderate pravastatin 40 mg (16% relative reduction, P=0.005).

Result

Composite of death, MI, unstable angina requiring rehospitalisation, revascularization, or stroke
Absolute difference
3.9 points
NNT
26
Effect estimate

relative reduction1695% CI 5-26 · P = 0.005

Absolute difference and NNT are derived from the event rates.

Also reported: Median achieved LDL-C 62 vs 95 mg/dL.

Original publication
Subtopic
Statins
Design
Double-blind, double-dummy, randomised active-comparator trial
Relevance
Important: one of several pillars.
Source
Cannon CP, et al. N Engl J Med. 2004;350(15):1495-1504.doi 10.1056/NEJMoa040583

Discussion & critique

Design confounds statin intensity with two different agents/doses so benefit cannot be attributed to LDL lowering alone. Established the 'lower is better' paradigm and high-intensity statin therapy as standard after acute coronary syndrome.